Aquestive Therapeutics Growth, Revenue, Number of Employees and Funding

Overview

Location:
Warren, NJ USA
Total Funding:$76.6M
Industry:Pharma
Founded:N/A
Lead Investor(s):BMO Capital Markets, RBC Capital Markets
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Aquestive Therapeutics's estimated revenue is currently $6.7M per year.
  • Aquestive Therapeutics received $73.9M in venture funding in August 2018.
  • Aquestive Therapeutics's estimated revenue per employee is $49197
  • Aquestive Therapeutics's total funding is $76.6M.

Employee Data

  • Aquestive Therapeutics has 137 Employees.
  • Aquestive Therapeutics grew their employee count by 22% last year.
  • Aquestive Therapeutics currently has 1 job openings.

Executive Contacts

NameTitle
Theresa WoodSVP HR
Mike HermanekQuality Assurance Director
Stephen WargackiDirector of CMC
Simon ScholteDirector of Technical Operations
Peter BoydSVP, Business Process & IT
Gary SlatkoSVP & Chief Medical Officer
Ed KorenkiewiczVP, Pricing & Market Access
Glen MottRegional Sales Director
Kara Leslie WhitmoreRegional Sales Director
Joseph CruscoDirector Business Development

What Is Aquestive Therapeutics?

Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people's lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.

keywords:N/A

137

Number of Employees

$6.7M

Revenue (est)

1

Current Jobs

22%

Employee Growth %

$76.6M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
TCP Reliable
$7.8M420%
TCP Reliable
$7.8M420%
Shionogi
$87M4808%
Trio, An FCB He...
$7.8M40-2%
Vertice Pharma
$7M39-7%
Ortho Dermatolo...
$43.2M24212%
PRI Healthcare ...
$11.5M56-5%
TAIHO ONCOLOGY ...
$35.8M1949%
LEO Pharma Inc....
$42.4M2323%
Specialty Rx
$19.9M12317%

Aquestive Therapeutics News

09/03/2019 - Market Sentiment Around Loss-Making Aquestive ...

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST): Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, ...

08/26/2019 - Aquestive Therapeutics to Attend Two Upcoming Investor ...

WARREN, N.J., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company ...

09/03/2019 - Short Interest in Aquestive Therapeutics Inc (NASDAQ:AQST ...

Aquestive Therapeutics Inc (NASDAQ:AQST) was the target of a significant decline in short interest during the month of July. As of July 31st, ...

Aquestive Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-08-16$73.9MUndisclosedBMO Capital MarketsArticle

Aquestive Therapeutics Executive Hires

DateNameTitleReference
2018-08-14Sandy CostaChairmanArticle
2018-09-12Lori BraenderSVP General CounselArticle
2019-01-04Gary SlatkoSVP, Chief Medical OfficerArticle